Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-133703
Filing Date
2024-12-05
Accepted
2024-12-05 16:22:07
Documents
6
Effectiveness Date
2024-12-05

Document Format Files

Seq Description Document Type Size
1 S-8 s-8_new_hire_inducement.htm S-8 250565
2 EX-5.1 achv-ex5_1.htm EX-5.1 12329
3 EX-23.2 achv-ex23_2.htm EX-23.2 3265
4 EX-99.1 achv-ex99_1.htm EX-99.1 564401
5 EX-FILING FEES achv-exfiling_fees.htm EX-FILING FEES 34204
6 GRAPHIC img223336490_0.jpg GRAPHIC 17749
  Complete submission text file 0000950170-24-133703.txt   890627
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-283630 | Film No.: 241529385
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)